Drachma,
At an EGM attendance in Feb 2011 the CEO noted that MSB were working towards an IND submission(FDA) re intervertebral disc cartliage trials in April 2011. Well now its May 2011 and it must be close.
Over the years MSB have had some outstanding trial results ( pre-clinical and clinicial.)
In relation to clinical the BMT and CHF phase II trails is what CEPH and now TEVA (mega speciality Pharma) have bought into ( amongst other future applications) on the back of postive interim results (refer previous MSB annoucements).
In relation to the many PRE-clinical trials that MSB have conducted, IMO the intervertebral disc cartilage PRE-clinical trials (2009) were the most striking (- see MSB release 10/9/2009 to make your own view).
Now in listeing to our CEO at February's EGM - this application is the crown jewels for the Meso Orthopedic business ( mkt estimated as >$2bn per year).
As mentioned by earlier posters we are expecting a couple of announcements which are nicely summarized by Bioshares report - 29/4/2011 ( see MSB website).
DYOR - cheers to all.
ann must be coming soon? , page-17
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $5.605M | 3.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 55197 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 29782 | 3 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |